Literature DB >> 25332632

Successful Pregnancy Outcome in Malaysian Woman with Rare p Phenotype and Anti-PP1P(k) Antibody.

M S Mohd Azri1, K Kunasegaran1, A Azrina2, A K Siti Nadiah2.   

Abstract

We report the first case of young woman with the p phenotype and anti-PP1P(k) antibody in the Malaysian population who was identified during a blood grouping and antibody screening procedure after her first miscarriage. Further family screening detected two other siblings who possessed the same rare phenotype and antibody. Because of difficulties in finding compatible units in the local population, the patient and her two siblings were advised to become regular blood donor. Their blood was frozen for future use. After she had two recurrent miscarriages, her third pregnancy was successfully managed using oral dydrogesterone, which was started from 10 weeks into the pregnancy. Her pregnancy was uneventful and she gave birth to a healthy term neonate.

Entities:  

Keywords:  Anti-PP1Pk; Dydrogesterone; Recurrent miscarriage; p phenotype

Year:  2014        PMID: 25332632      PMCID: PMC4192202          DOI: 10.1007/s12288-014-0439-4

Source DB:  PubMed          Journal:  Indian J Hematol Blood Transfus        ISSN: 0971-4502            Impact factor:   0.900


  13 in total

Review 1.  Frozen red cells.

Authors:  H T Meryman
Journal:  Transfus Med Rev       Date:  1989-04

2.  Anti-PP1Pk (anti-Tja) and habitual abortion.

Authors:  D B Weiss; C Levene; Y Aboulafia; M Isacsohn
Journal:  Fertil Steril       Date:  1975-09       Impact factor: 7.329

3.  Dydrogesterone in threatened abortion: pregnancy outcome.

Authors:  M H Omar; M K Mashita; P S Lim; M A Jamil
Journal:  J Steroid Biochem Mol Biol       Date:  2005-11-15       Impact factor: 4.292

4.  Dydrogesterone in the reduction of recurrent spontaneous abortion.

Authors:  M Y El-Zibdeh
Journal:  J Steroid Biochem Mol Biol       Date:  2005-10-25       Impact factor: 4.292

5.  The proper use of previously frozen red blood cells for transfusion.

Authors:  H Chaplin
Journal:  Blood       Date:  1982-06       Impact factor: 22.113

6.  Successful management of a P-incompatible pregnancy using double filtration plasmapheresis.

Authors:  Fuminori Taniguchi; Sayako Horie; Saroru Tsukihara; Naoki Nagata; Kenichi Nishikawa; Naoki Terakawa
Journal:  Gynecol Obstet Invest       Date:  2003-08-26       Impact factor: 2.031

7.  P phenotype observed in two generations of Tunisian family with a high rate of inbreeding.

Authors:  D Salmon; S Bouchmel; A Hafsia; S Boussen; M Boussen; A Bouguerra
Journal:  Rev Fr Transfus Immunohematol       Date:  1979-12

8.  A progesterone-induced protein increases the synthesis of asymmetric antibodies.

Authors:  K Kelemen; I Bognar; M Paal; J Szekeres-Bartho
Journal:  Cell Immunol       Date:  1996-01-10       Impact factor: 4.868

9.  Removal of maternal antibodies from a woman with repeated fetal loss due to P blood group incompatibility.

Authors:  H Yoshida; K Ito; T Kusakari; K Ida; Y Ihara; T Mori; M Matsumura
Journal:  Transfusion       Date:  1994-08       Impact factor: 3.157

10.  Hemolytic disease of the newborn due to anti-PP1 P k (anti-Tj a).

Authors:  C Levene; R Sela; Y Rudolphson; I Nathan; M Karplus; A Dvilansky
Journal:  Transfusion       Date:  1977 Nov-Dec       Impact factor: 3.157

View more
  3 in total

1.  Comparative analysis of antigen coding genes in 15 red cell blood group systems of Yunnan Yi nationality in China: A cross-sectional study.

Authors:  Kun-Hua He; Lu-Qiong Xu; Ying-Feng Hu; Yin-Xia Xu; Yu Zhao; Jing-Yan Bao; Bu-Qiang Wang
Journal:  Health Sci Rep       Date:  2022-10-17

2.  The synonymous 903C>G mutation in the alpha 1,4-galactosyltransferase gene in a Chinese woman with habitual abortion: A case report.

Authors:  Xiaoying Lv; Yongquan Chen; Yuanyuan Luo; Lingbo Li; Houzhao Wang
Journal:  Medicine (Baltimore)       Date:  2019-08       Impact factor: 1.817

3.  Blood Group Discrepancies at a Regional Blood Center.

Authors:  Hayedeh Javadzadeh Shahshahani; Azam Hayati
Journal:  Int J Hematol Oncol Stem Cell Res       Date:  2020-01-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.